Using
a function-oriented synthesis strategy, we designed, synthesized,
and evaluated the simplest bryostatin 1 analogues reported to date,
in which bryostatin’s A- and B-rings are replaced by a glutarate
linker. These analogues, one without and one with a C26-methyl group,
exhibit remarkably different protein kinase C (PKC) isoform affinities.
The former exhibited bryostatin-like binding to several PKC isoforms
with K
i’s < 5 nM, while the
latter exhibited PKC affinities that were up to ∼180-fold less
potent. The analogue with bryostatin-like PKC affinities also exhibited
bryostatin-like PKC translocation kinetics in vitro, indicating rapid cell permeation and engagement of its PKC target.
This study exemplifies the power of function-oriented synthesis in
reducing structural complexity by activity-informed design, thus enhancing
synthetic accessibility, while still maintaining function (biological
activity), collectively providing new leads for addressing the growing
list of therapeutic indications exhibited by PKC modulators.